http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2011153742-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-1088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-624 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-626 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-1027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5123 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-04 |
| filingDate | 2010-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2011153742-A |
| titleOfInvention | Restoration of coronary arteries by improving blood flow through the introduction of nanospheres (encapsulated nanoparticles) comprising a therapeutic agent, THROUGH NEIMPLANTIRUEMOGO DEVICES AND TISSUE thereby providing release into the tissue so that addresses the need of the cell cycle |
| abstract | 1. A medical device delivering a medicine, which includes: a catheter balloon, an inflatable balloon located on the catheter balloon, wherein the inflatable balloon has a hydrophilic surface, wherein at least one portion of the hydrophilic surface is coated with a plurality of nanocarriers, wherein the nanocarrier is from a plurality of nanocarriers includes a drug surrounded by an encapsulating medium, where the surface of the nanocarrier is devoid of the drug, and from 30% to 80% of the many nanocarriers are released with hydrophobic the surface for 15-90 s when inflating the inflatable balloon after approaching close to the destination in the lumen of a part of the body. 2. A medical device delivering a medicine according to claim 1, wherein the encapsulating medium comprises at least one of a biological agent, a phospholipid, and a blood-based excipient. The medical device delivering the medicine according to claim 1, wherein the inflatable balloon has a distal end and a proximal end, and at least a portion of the distal end of the inflatable balloon and at least a portion of the proximal end of the inflatable balloon are not coated with a plurality of nanocarriers. The medical device delivering the drug according to claim 2, wherein the biological agent and the phospholipid have at least one effect selected from the group including affinity for the destination and stabilization of the drug. The medical device delivering the drug according to claim 2, wherein the biological agent is dissolved in an environment having a pH of less than 7.4.6. The medical device delivering the drug according to claim 1, |
| priorityDate | 2009-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 222.